To be, or not to be BAME, in the time of COVID-19: does it matter?F Aaysha Cader, Clyde W Yancy, Shrilla Banerjee
8 March 2021
Racial differences in management and outcomes of acute myocardial infarction during COVID-19 pandemicMuhammad Rashid, Adam Timmis, Tim Kinnaird, Nick Curzen, Azfar Zaman, Ahmad Shoaib, Mohamed O Mohamed, Mark A de Belder, John Deanfield, Glen Philip Martin, Jianhua Wu, Chris P Gale, Mamas Mamas
8 March 2021
If not now, when? Enhancing cardiologists’ psychological well-being as a COVID-19 gainRishi K Patel, Mark D Sweeney, Christopher S R Baker, Neil Greenberg, Susan E Piper, Sukhi S Shergill, Derek K Tracy, Carla M Plymen
8 January 2021
COVID-19 pandemic: preventing hospital myocardial infarction admissions or preventing acute myocardial infarction altogether?Nicolas Danchin, Eloi Marijon
1 February 2021
Effect of the COVID-19 pandemic on mortality of patients with STEMI: a systematic review and meta-analysisManuel Rattka, Jens Dreyhaupt, Claudia Winsauer, Lina Stuhler, Michael Baumhardt, Kevin Thiessen, Wolfgang Rottbauer, Armin Imhof
17 December 2020
Heartbeat: higher risk of COVID-19 infection in younger patients with cardiovascular diseaseCatherine M Otto
11 February 2021
Heartbeat: the COVID-19 pandemic and the future of cardiologyCatherine M Otto
11 January 2021
Place and causes of acute cardiovascular mortality during the COVID-19 pandemicJianhua Wu, Mamas A Mamas, Mohamed O Mohamed, Chun Shing Kwok, Chris Roebuck, Ben Humberstone, Tom Denwood, Thomas Luescher, Mark A de Belder, John E Deanfield, Chris P Gale
28 September 2020
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million peopleJulia Hippisley-Cox, Pui San Tan, Carol Coupland
5 November 2020
Risk of COVID-19 and smokingIvan Berlin
4 November 2020